LON:AGL - ANGLE Stock Price, News & Analysis

GBX 71
-1.50 (-2.07 %)
(As of 08/16/2019 04:00 PM ET)
Today's Range
Now: GBX 71
50-Day Range
MA: GBX 70.39
52-Week Range
Now: GBX 71
Volume150,744 shs
Average Volume106,228 shs
Market Capitalization£122.66 million
P/E RatioN/A
Dividend YieldN/A
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. It develops and commercializes Parsortix cell separation system, which captures and harvests rare circulating tumor cells in cancer patient blood; and Ziplex multiplex analysis system that is used with the ovarian cancer clinical application and others. The company was founded in 2004 and is based in Guildford, the United Kingdom.

Industry, Sector and Symbol

Industry Medical Laboratories & Research



Sales & Book Value

Annual Sales£678,000.00
Cash FlowGBX 7.24 per share
Book ValueGBX 13.50 per share



Market Cap£122.66 million
Next Earnings DateN/A
OptionableNot Optionable

Receive AGL News and Ratings via Email

Sign-up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter.

ANGLE (LON:AGL) Frequently Asked Questions

What is ANGLE's stock symbol?

ANGLE trades on the London Stock Exchange (LON) under the ticker symbol "AGL."

Has ANGLE been receiving favorable news coverage?

News stories about AGL stock have trended negative recently, InfoTrie Sentiment reports. The research group identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. ANGLE earned a coverage optimism score of -2.3 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for ANGLE.

Who are some of ANGLE's key competitors?

What other stocks do shareholders of ANGLE own?

Who are ANGLE's key executives?

ANGLE's management team includes the folowing people:
  • Mr. Andrew David William Newland, Founder, CEO & Exec. Director (Age 57)
  • Mr. Ian Francis Griffiths, CFO, Fin. Director, Company Sec. & Exec. Director (Age 54)
  • Dr. Daniel J. O'Shannessy, Chief Scientific Officer
  • Mr. Paul Smith, VP & Chief Exec. Officer of ANGLE Biosciences Inc
  • Mr. Martin Cooke, Director of Manufacturing & Regulatory Affairs (Age 50)

How do I buy shares of ANGLE?

Shares of AGL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is ANGLE's stock price today?

One share of AGL stock can currently be purchased for approximately GBX 71.

How big of a company is ANGLE?

ANGLE has a market capitalization of £122.66 million and generates £678,000.00 in revenue each year. ANGLE employs 43 workers across the globe.View Additional Information About ANGLE.

What is ANGLE's official website?

The official website for ANGLE is http://www.angleplc.com/.

How can I contact ANGLE?

ANGLE's mailing address is The Surrey Research Park 3 Frederick Sanger Road, GUILDFORD, GU2 7YD, United Kingdom. The company can be reached via phone at +44-1483-685830.

MarketBeat Community Rating for ANGLE (LON AGL)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  135 (Vote Outperform)
Underperform Votes:  198 (Vote Underperform)
Total Votes:  333
MarketBeat's community ratings are surveys of what our community members think about ANGLE and other stocks. Vote "Outperform" if you believe AGL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AGL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/17/2019 by MarketBeat.com Staff

Featured Article: Retained Earnings

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel